Biomerica, Inc.BMRANASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-15100.00%
↓ 3250% below average
Average (39q)
-450.78%
Historical baseline
Range
High:101.88%
Low:-15100.00%
CAGR
+13.7%
Consistent expansion
| Period | Value |
|---|---|
| Q4 2025 | -15100.00% |
| Q3 2025 | 101.88% |
| Q2 2025 | -135.64% |
| Q1 2025 | -22.34% |
| Q4 2024 | 29.03% |
| Q3 2024 | 7.46% |
| Q2 2024 | 23.18% |
| Q1 2024 | -22.77% |
| Q4 2023 | -33.14% |
| Q3 2023 | 38.82% |
| Q2 2023 | 8.33% |
| Q1 2023 | 0.00% |
| Q4 2022 | 25.00% |
| Q3 2022 | -14.29% |
| Q2 2022 | -1628.40% |
| Q1 2022 | 91.00% |
| Q4 2021 | 25.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 25.00% |
| Q1 2021 | -23.08% |
| Q4 2020 | 7.14% |
| Q3 2020 | -238.16% |
| Q2 2020 | 54.00% |
| Q1 2020 | -80.00% |
| Q4 2019 | 3.85% |
| Q3 2019 | 36.82% |
| Q2 2019 | -13.05% |
| Q1 2019 | -38.14% |
| Q4 2018 | -4.15% |
| Q3 2018 | 34.11% |
| Q2 2018 | -103.71% |
| Q1 2018 | -19.68% |
| Q4 2017 | -29.63% |
| Q3 2017 | 40.15% |
| Q2 2017 | -12.47% |
| Q1 2017 | -45.56% |
| Q4 2016 | -264.71% |
| Q3 2016 | 95.47% |
| Q2 2016 | -747.46% |
| Q1 2016 | -101.14% |